University of Exeter: University spin-out company aiming to treat degenerative disease announces funding

A biotech company which aims to harness University of Exeter research to develop new therapeutics to stop the progression of degenerative diseases has received new seed financing. MitoRx Therapeutics (MitoRx), is initially focussing on developing a n

Related Keywords

United Kingdom ,Exeter ,Devon ,Oliver Sexton ,Jon Rees ,Matt Whiteman ,University Of Exeter Medical School ,Science Angel Syndicate Network ,United Kingdom Innovation Science Seed Fund ,Fink Family Office ,University Of Exeter ,Oxford Technology Management ,Glyn Edwards ,Prof Matt Whiteman ,Exeter Medical School ,Norman Law ,Investment Director ,United Kingdom Innovation ,Science Seed Fund ,Mitorx Therapeutic ,Wren Capital ,